96768 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
Peptides binding to vascular endothelial growth factor
#1502Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
#1503Methods for Treating Body Tissue
#1504METHODS AND COMPOSITIONS FOR PROTEIN PURIFICATION
#1505Methods for Treating Body Tissue
#1506Composition and method for preventing or treating a virus infection
#1507Anti-Viral Peptide and Use Thereof
#1508Thiosuccinic acid derivatives and the use thereof
#1509PROCESS FOR IMMOBILIZING ORIENTATION-CONTROLLED PROTEIN AND PROCESS FOR ARRAYING AND IMMOBILIZING PROTEIN USING THE SAME
#1510Methods for making and using molecular switches involving circular permutation
#1511Therapeutic and diagnostic peptides
#1512METHOD FOR IDENTIFYING HAIR CONDITIONER-RESISTANT HAIR-BINDING PEPTIDES AND HAIR BENEFIT AGENTS THEREFROM
#1513Methods for production of unstructured recombinant polymers and uses thereof
#1514Antimicrobial peptides
#1515Polypeptide Connected With an Organic Residue
#1516PEPTIDES HAVING AFFINITY FOR BODY SURFACES
#1517Peptide vaccines against Group A streptococci
#1518Methods and compositions for promoting localization of pharmaceutically active agents to bone
#1519Triazole macrocycle systems
#1520Synthetic approach to designed chemical structures
#1521COMPOSITIONS AND METHODS FOR TREATING INFECTIONS USING ANALOGUES OF INDOLICIDIN
#1522Copolymers for suppression of autoimmune diseases, and methods of use
#1523Antimicrobial Peptides
#1524Microcin B17 Analogs And Methods For Their Preparation And Use
#1525Selective delivery of molecules into cells or marking of cells in diseased tissue regions using environmentally sensitive transmembrane peptide
#1526RNA targeting compounds and methods for making and using same
#1527Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
#1528Polynucleotides encoding chimeric GFP-aequorin as bioluminescent Ca++ reporters
#1529GFP-SNAP25 fluorescence release assay for botulinum toxin protease activity
#1530Antimicrobial peptides
#1531Compositions and Methods For Modulating Dopamine Nerutransmission
#1532Polytetrafluoroethylene binding peptides and methods of use
#1533Synthetic peptides and methods of use for autoimmune disease therapies
#1534COMPOUNDS AS APTAMER-DIMERS AND THEIR USES IN DIAGNOSIS AND THERAPY
#1535Anti-Angiogenic Peptides and Methods of Use Thereof
#1536Method of Preparing Grafted Polylysine Dendrimers
#1537Functional peptide fiber, production thereof and method for recovering peptide chains
#1538Method For Screening Modulators of Mitochondrial Functioning and New Modulators Obtained
#1539PEPTIDE DERIVATIVES, AND THEIR USE FOR THE SYNTHESIS OF SILICON-BASED COMPOSITE MATERIALS
#1540VEGFR-1 TARGETING PEPTIDES
#1541Recombinant Production of Polyanionic Polymers, and Uses Thereof
#1542GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
#1543Peptides Having For Example Antiangiogenic Activity and Applications Thereof In Therapeutics
#1544GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
#1545Selectively targeted antimicrobial peptides and the use thereof
#1546GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity
#1547BIODEGRADABLE, ANIONIC POLYMERS DERIVED FROM THE AMINO ACID L-TYROSINE
#1548Glycoconjugation methods and proteins/peptides produced by the methods
#1549sFRP and peptide motifs that interact with sFRP and methods of their use
#1550Isolating biological modulators from biodiverse gene fragment libraries
#1551Peptide compositions for targeting adipose tissue
#1552Tannate salt form of polypeptide mixtures, their preparation and use
#1553PEPTIDE-BASED CONDITIONERS
#1554Targeting vector-phospholipid conjugates
#1555Protein structure
#1556Methods and Compositions for Reducing a Level of a Toxic Protein in a Cell
#1557Peptides for treatment of scleroderma
#1558Orally administered peptides synergize statin activity
#1559ORALLY ADMINISTERED PEPTIDES SYNERGIZE STATIN ACTIVITY
#1560Compositions and Methods for Inhibiting Cellular Proliferation
#1561Compositions and methods for polynucleotide delivery
#1562Methods of constructing and screening libraries of peptide structures
#1563Thrombopoietic compounds
#1564Methods and Compositions Relating to Lipid Accumulation
#1565FLUORESCENCE RESONANCE ENERGY TRANSFER (FRET) ASSAYS FOR CLOSTRIDIAL TOXIN ACTIVITY
#1566Process for the preparation of poly-alpha-glutamic acid and derivatives thereof
#1567Method of preparing bivalirudin
#1568Orally administered peptides synergize statin activity
#1569Unstructured recombinant polymers and uses thereof
#1570FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
#1571Medical device coated with a coating containing elastin pentapeptide VGVPG
#1572Peptide motifs for binding avidin or neutravidin
#1573FRET PROTEASE ASSAYS FOR CLOSTRIDIAL TOXINS
#1574Glycopeptides and Temperature-Responsive Micelles
#1575Processes for preparing a polypeptide
#1576PROCESS FOR THE PREPARATION OF COPOLYMER-1
#1577Metal binding compounds, metal binding compositions, and their uses
#1578Polypeptide and process for producing the same
#1579Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
#1580Endometriosis cell targeting peptide and uses thereof
#1581Collagen Mimics
#1582Copolymer comprising elastin pentapeptide block and hydrophilic block, and medical device and method of treating
#1583Collagen mimics
#1584Methods, peptides and biosensors useful for detecting a broad spectrum of bacteria
#1585C-type lectin fold as a scaffold for massive sequence variation
#1586PMMA binding peptides and methods of use
#1587Polystyrene binding peptides and methods of use
#1588Antimicrobial Peptides
#1589Orally administered peptides synergize statin activity
#1590Clay-binding peptides and methods of use
#1591Luminescence resonance energy transfer (LRET) assays for clostridial toxin activity
#1592MULTIPLE ANTIGEN GLYCOPEPTIDE CARBOHYDRATE, VACCINE COMPRISING THE SAME AND USE THEREOF
#1593Methods of treatment using specific binding agents of human angiopoietin-2
#1594Proteinaceous pharmaceuticals and uses thereof
#1595Biomarkers of vulnerable atherosclerotic plaques and methods of use
#1596Compositions and methods for inhibiting cellular proliferation
#1597Novel Glp-1 Derivatives
#1598Methods and systems for generating and evaluating peptides
#1599Phage displayed cell binding peptides
#1600Peptidyl diacylglycerides
#1601Method for identifying hair conditioner-resistant hair-binding peptides and hair benefit agents therefrom
#1602Proteinaceous pharmaceuticals and uses thereof
#1603Methods for production of proteins
#1604Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor
#1605Methods for production of proteins
#1606Methods of screening for useful proteins
#1607Cytokine zalpha11 ligand fusion proteins
#1608Methods and compositions for prolonging elimination half-times of bioactive compounds
#1609Peptide-tagged proteins and methods of making and using thereof
#1610Polypeptide having collagen-like structure
#1611Block Copolypeptide vesicle based materials for drug delivery
#1612Peptides that home to tumor lymphatic vasculature and methods of using same
#1613Process for the preparation of copolymer-1
#1614Nylon binding peptides and methods of use
#1615Polyethylene binding peptides and methods of use
#1616Compound and method of treatment
#1617Biofunctional, antimicrobial coatings for medical devices
#1618CYTOKINE ZALPHA11 LIGAND
#1619Compositions and liquid crystals
#1620Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
#1621CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#1622CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#1623Methods of treatment using specific binding agents of human angiopoietin-2
#1624Methods of treatment using specific binding agents of human angiopoietin-2
#1625Prion-specific peptoid reagents
#1626Methods of treatment using specific binding agents of human angiopoietin-2
#1627Cytokine zalpha11 ligand fusion proteins
#1628Cytokine zalpha11 ligand fusion proteins
#1629Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#1630Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
#1631Template-fixed peptidomimetics with antimicrobial activity
#1632Cytokine zalpha11 ligand antibodies and methods of use
#1633Methods of using cytokine zalpha11 ligand
#1634CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#1635Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#1636Cytokine zalpha11 ligand fusion proteins
#1637Method of use of cytokine ZALPHA11 ligand
#1638CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#1639Apparatus and method for automated protein design
#1640Antimicrobial agents
#1641Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
#1642Metal chelate complexes immobilized on solid supports for peptide preparation
#1643Peptides that bind to the erythropoietin receptor
#1644Coloring compositions with peptide-based dispersants and binders
#1645Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
#1646Process for preparation of mixtures of polypeptides using purified hydrobromic acid
#1647Peptidic nanoparticles as drug delivery and antigen display systems
#1648Cytokine zalpha11 ligand antibodies
#1649Methods for production of proteins
#1650Branched cationic copolymers and methods for antimicrobial use
#1651Artificial antibody comprising complementary peptide
#1652Polysialic acid derivatives
#1653Methods of production of proteins
#1654Apparatus and method for automated protein design
#1655Compounds that bind to growth hormone receptor
#1656Multimeric apoprotein agonists
#1657Unnatural reactive amino acid genetic code additions
#1658Peptidomimetic polymers for antifouling surfaces
#1659Method of immobilizing a protein to a zeolite
#1660Peptides able to switch between two structural states and their use
#1661Template-fixed peptidomimetics as medicaments against HIV and cancer
#1662Serum albumin binding peptides for tumor targeting
#1663Hybrid oligomers, their preparation process and pharmaceutical compositions containing them
#1664Surfactant peptide nanostructures, and uses thereof
#1665Inhibitors of proteins from the rho-gef family
#1666Mutant protein
#1667Glycosylated specificity exchangers
#1668Synthetic approach to designed chemical structures
#1669Protein lattice
#1670Water-soluble thioester and selenoester compounds and methods for making and using the same
#1671Process for producing polypeptide mixtures using hydrogenolysis
#1672Anti-angiogenic peptides and methods of use thereof
#1673Peptides that selectively home to heart vasculature and related conjugates and methods
#1674Fiber-shaping peptides capable of interacting with self-assembling peptides
#1675Processes for preparing a polypeptide
#1676Beta sheet tapes ribbons in tissue engineering
#1677GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
#1678Sustained delivery of PDGF using self-assembling peptide nanofibers
#1679Gene and protein libraries and methods relating thereto
#1680Ultra-high specificity fluorescent labeling
#1681Peptides and related molecules that bind to TALL-1
#1682Multifunctional context-activated protides and methods of use
#1683Partial peptide mimetics and methods
#1684Specific binding agents of human angiopoietin-2
#1685Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseases
#1686Peptides having affinity for the gp120 viral protein and use thereof
#1687Streptavidin-binding peptide
#1688Tenascin-C nucleic acid ligands
#1689Composition and method for increasing apoptosis in cancer cells
#1690Conductive peptide nanofiber and method of manufacture of the same
#1691Purification of recombinant proteins fused to multiple epitopes
#1692Systematic evolution of ligands by exponential enrichment: Chemi-SELEX
#1693Targeted delivery of biological factors using self-assembling peptide nanofibers
#1694High affinity TGFbeta nucleic acid ligands and inhibitors
#1695Growth factor binding molecules
#1696Antimicrobial agents
#1697Multifunctional context-activated protides and methods of use
#1698Small molecule mimetics of erythropoietin
#1699Antimicrobial polypeptide and utilization thereof
#1700Process for preparation of mixtures of polypeptides using purified hydrobromic acid
#1701Biofunctional coatings
#1702IFBMs to promote the specific attachment of target analytes to the surface of orthopedic implants
#1703Compostions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
#1704Peptides and compounds that bind to a receptor
#1705Peptides that bind to the erythropoietin receptor
#1706Cyclic molecular framework and derivatives thereof
#1707Methods for treating body tissue
#1708Apparatus and method for automated protein design
#1709Protein structures and protein fibres
#1710Stabilized compounds having secondary structure motifs
#1711Polypeptide compositions formed using a coiled-coil template and methods of use
#1712Isolating biological modulators from biodiverse gene fragment libraries
#1713Peptide chemically modified with polyethylene glycol
#1714Carboxy protection strategies for acidic C-terminal amino acids in chemical ligation of oligopeptides
#1715Method for producing transgenic plants resistant to weed control compounds which disrupt the porphyrin pathways of plants
#1716Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#1717KDR and VEGF/KDR binding peptides
#1718Stabilized alpha helical peptides and uses thereof
#1719Polypeptide scaffolds and use thereof
#1720Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
#1721Peyer's patch and/or M-cell targeting ligands
#1722Peptides and related molecules that modulate nerve growth factor activity
#1723Peptide vaccines against group A streptococci
#1724Antimicrobial peptide, its analogs and antimicrobial composition comprising them
#1725aPL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies
#1726Peptides for inducing apoptosis in tumor cells
#1727Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
#1728Periodic antimicrobial peptides
#1729Protein variants having modified immunogenicity
#1730Specific detection of proteolytic enzymes
#1731Nucleic acid ligand complexes
#1732Endotheliase-1 ligands
#1733Self-assembling-peptide-based structures and processes for controlling the self-assembly of such structures
#1734Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX
#1735Mutated immunoglobulin-binding protein
#1736Peptides that bind to the erythropoietin receptor
#1737Truncation SELEX method
#1738Pharmacologically active antiviral peptides
#1739Recombinant production of polyanionic polymers, and uses thereof
#1740GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
#1741KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
#1742Self-assembling polymers, and materials fabricated therefrom
#1743Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
#1744Glycosylated specificity exchangers
#1745Biopanning and rapid analysis of selective interactive ligands (brasil)
#1746Multiple-arm peptide compounds, methods of manufacture and use in therapy
#1747Induction of immune response against desired determinants
#1748Antimicrobial cationic peptides and formulations thereof
#1749Synthetic peptide having an ionophoric and antimicrobial activity
#1750High affinity RNA ligands of basic fibroblast growth factor
#1751Apparatus and method for automated protein design
#1752Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
#1753Collagen mimics
#1754Fusion peptide inhibitors of human coronavirus 229E
#1755Fusion peptide inhibitors of human coronavirus 229E
#1756Fusion peptide inhibitors of human coronavirus 229E
#1757Synthetic plasmodium antigens, compositions, and uses thereof
#1758Invention of non-homologous peptide sequences to interact with amyloid beta and its precursor protein APP by using computer modeling
#1759Functionalizing biological substrates with bioengineered peptides to bind targeted molecules
#1760Peptide inhibitors of CRISPR-Cas9
#1761Controlled synthesis of hierarchically-structured hybrid materials through peptoid engineering